gliclazide Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Gliclazide, sold under the brand name Diamicron among others, is a sulfonylurea type of anti-diabetic medication, used to treat type 2 diabetes. It is used when dietary changes, exercise, and weight loss are not enough. It is taken by mouth.   Wikipedia

Chemistry

  • SMILES: Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2
  • InChIKey: BOVGTQGAOIONJV-UHFFFAOYSA-N
  • Mol. Mass: 323.42
  • ALogP: 1.63
  • ChEMBL Molecule:
    gliclazide  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Drug Pricing (per unit)

Australia

$0.0454 - $0.1920
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

1-(3-azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea | 1-(hexahydrocyclopenta(c)pyrrol-2(1h)-yl)-3-(p-tolylsulfonyl)urea | bilxona | dacadis mr | diabezidum | diabrezide | diabyl | diaglyk | diamicron | diamicron mr | diaprel | dizalid | edicil | glicazide | gliclazid | gliclazida | gliclazide | gliclazidum | glimicron | glimil | glinormax | glyzide | n-(4-methylbenzenesulfonyl)-n'-(3-azabicyclo(3.3.0)oct-3-yl)urea | nazdol mr | s 1702 | se-1702 | vamju | vitile xl | ziclaseg | zicron | zicron pr

Organizations (59)

Research & Development (59)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (13)

Approved Indications (1)


 

Diabetes Mellitus, Type 2

Experimental Indications - Clinical Trial Phases 1-4 (13)


 

Angina Pectoris (Phase 4)

Bone Diseases, Metabolic (Phase 4)

Diabetes Mellitus ()

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Nephropathies (Phase 4)

Endothelium (Phase 3)

Epilepsy (Phase 1)

Healthy Volunteers (Phase 1)

Menopause (Phase 4)

Non-alcoholic Fatty Liver Disease (Phase 4)

Osteoporosis (Phase 4)

Pharmacology (Phase 1)

Psoriasis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 48
  • # of Trial Organizations: 59

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue